Agomelatine
A Novel Therapeutic Agent for Rheumatoid Arthritis, Agomelatine (AOM) is a promising pharmacological agent that has shown significant therapeutic potential in combating rheumatoid arthritis (RA), a chronic autoimmune disease characterized by inflammation and joint destruction. Recent studies have revealed AOM's efficacy in inhibiting tumor necrosis factor-alpha (TNFα) -mediated inflammation, a crucial pathway involved in RA pathogenesis.
Cinacalcet
Cinacalcet an FDA approved drug which kills bacteria by destroying bacterial membrane as well as respiratory metabolism and is used to treat secondary hyperparathyroidism and parathyroid cancer. It can also kill bacteria by producing reactive oxygen species (ROS). It was revealed by Limited Proteolysis -Small molecule mapping (LiP-SMap) that cinacalcet inhibits biofilm formation by targeting IcaR. Cinacalcet can partially remove the biofilm of drug-resistant S. aureus in an animal model it was revealed by in vitro and in vivo experiments . These findings suggest that cinacalcet has antibacterial and antibiofilm capabilities.
2 アイテム